key: cord-1035870-6kzbueh2
authors: Mortazavi, Seyed Alireza; Bevelacqua, Joseph J; Rafiepour, Payman; Ghadimi-Moghadam, AbdolKarim; Saraie, Pooya; Jooyan, Najmeh; Mortazavi, Seyedeh Hanieh; Javad Mortazavi, Seyed Mohammad; Welsh, James S
title: Revisiting the Paradox of Smoking: Radioactivity in Tobacco Smoke or Suppressing the SARS-CoV-2 Receptor, Angiotensin-Converting Enzyme 2, via Aryl-Hydrocarbon Receptor Signal?
date: 2022-04-01
journal: Dose Response
DOI: 10.1177/15593258221075111
sha: a8eb684264af4455318ac330e46509cd917dba41
doc_id: 1035870
cord_uid: 6kzbueh2

Despite current controversies, some reports show a paradoxical mitigating effect associated with smoking in individuals with symptomatic COVID-19 compared to the general population. To explain the potential mechanisms behind the lower number of hospitalized COVID-19 patients, it has been hypothesized that cigarette smoking may reduce the odds of cytokine storm and related severe inflammatory responses through cholinergic-mediated anti-inflammatory mechanisms. Japanese scientists have recently identified a potential mechanism behind the lower numbers of COVID-19 cases amongst smokers compared to non-smokers. However, we believe that this mitigative effect may be due to the relatively high concentration of deposited energy of alpha particles emitted from naturally occurring radionuclides such as Po-210 in cigarette tobacco. Regarding COVID-19, other researchers and our team have previously addressed the anti-inflammatory and immune-modulating effects of low doses of ionizing radiation. MC-simulation using the Geant4 Monte Carlo toolkit shows that the radiation dose absorbed in a spherical cell with a radius of .9 μm for a single 5.5 MeV alpha particle is about 5.1 Gy. This energy deposition may trigger both anti-inflammatory and anti-thrombotic effects which paradoxically lower the risk of hospitalization due to COVID-19 in smokers.

The purpose of this paper is to outline the perplexing connection between smoking and COVID-19. It is not intended to advocate or endorse smoking, which has known negative health consequences. The paper offers a hypothetical mechanism as well as some information of potential interest in the treatment of smokers who have contracted or are just presenting symptoms of COVID-19.

Smoking is the global leading cause of respiratory diseases. 1 COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a deadly pandemic without any widely accepted specific treatment after its identification in 2019. There are some reports suggesting smoking increases the severity of However, other reports paradoxically show a mitigative effect might be associated with patients smoking at a lower rate in individuals with symptomatic COVID-19 compared to the general population or a decreased severity of COVID-19 disease and death. [6] [7] [8] Moreover, a causal effect of smoking on the risk of severe COVID-19 is reported by some researchers, 9 but Paleiron et al. have reported that current smoking status can be associated with a lower risk of developing severe However, they noted that smoking cannot be considered as efficient protection against infection and stated that the mechanisms behind the decreased susceptibility of smokers to SARS-CoV-2 require further research. Given this consideration, here we present some possible protective mechanisms of action of smoking in COVID-19.

To explain the reason for the lower number of hospitalized patients, it has been hypothesized that cigarette smoking may have preventative effects on cytokine storm and severe related inflammatory responses through cholinergic-mediated antiinflammatory mechanisms. 11 In Italy, the very low number of COVID-19 patients who are smokers suggests that there is not a significant positive relationship between smoking and the prevalence of severe COVID-19. 12 It has also been reported that the lower numbers of COVID-19 cases amongst smokers might be due to the effects of nicotine. It should be noted that nicotine has previously been reported to downregulate the ACE-2 receptor. 13 However, other reports contradict the protective effects of nicotine, as claimed in some reports, 14,15 and show that the effect of being a current smoker is possibly very small. 16

Researchers at Hiroshima University have identified a potential mechanism behind the lower numbers of COVID-19 cases amongst smokers compared to non-smokers. 17 They reported that cigarette smoke extract (CSE) may suppress the expression of the angiotensin-converting enzyme 2 (ACE-2) receptor, (the receptor for SARS-CoV-2), which in turn would result in lower cellular entry of the virus (by decreasing available binding sites for the virus), thereby limiting the progression of the disease. 17 However, other researchers believed cigarette smoking may be related to COVID-19 through the link between nicotine and higher ACE-2 expression in different groups of cells such as lung and airway epithelium. 18-21 Moreover, Voinsky et al have reported that due to higher bronchial TMPRSS4 levels (which codes for a protease that primes COVID-19 virus for entering cells), smokers are more susceptible to COVID-19 infection risk than non-smokers. 22 Therefore, there is ongoing controversy over the effect of smoking on ACE-2 expression.

While the lower numbers of COVID-19 cases amongst smokers has been linked to nicotine, the report published by Hiroshima University introduces the potential effects of polycyclic aromatic hydrocarbons (PAHs) and activation of arylhydrocarbon receptors (AHRs). However, we believe that the lower numbers of COVID-19 cases amongst smokers can be due to the high concentration of deposited energy of alpha particles emitted from naturally occurring radionuclides such as Po-210 in cigarette tobacco. 23 There are more than 6000 identified chemical compounds in tobacco and tobacco smoke. 1,24-27 The presence of radioactive polonium-210 ( 210 Po) and lead-210 ( 210 Pb) in tobacco and tobacco smoke was identified a long time ago (Figure 1 ).

The activity of the alpha-emitting radionuclide 210 Po is estimated to range from 5.5 to 17.8 mBq/cigarette with the mean value of 12.0 mBq/cigarette. 210 Pb which is also present in cigarette smoke can also emit alpha particles. 28,29 Besides 210 Po, there are other radionuclides in cigarette smoke such as 238U, 232Th, 226Ra, 228Ra, 214Bi, and 40K. 29-31 Due to the relatively high activity of 210 Po and 210 Pb in tobacco, smoking has been reported to increase the internal intake of both of these radionuclides and that results in an increase in the internal radiation dose, which may promote development of lung cancer. 32-34 However, other researchers and our team have previously addressed the anti-inflammatory and immune-modulating effects of low doses of ionizing radiation. [35] [36] [37] [38] Given this consideration, smokers are constantly exposed to low doses of high linear energy transfer (LET) alpha particles due to inhalation of radionuclides such as 210 Po and 210 Pb in cigarette smoke. 39-41 Therefore, the anti-inflammatory effects of localized radiation via alpha particles as well as the effect of low doses of radiation on reducing the risk of thrombosis are possibly involved in the lower number of hospitalized smokers than expected. 23, 42, 43 Mont Carlo Simulation MC simulation, using Geant4 Monte Carlo toolkit [29] , shows that the radiation dose absorbed in a spherical cell with a radius of .9 μm for a single 5.5-MeV alpha particle is about 5.1 Gy. Figure 2 shows the trajectory of alpha particles through a spherical cell of water. The alpha particles were emitted from a circular plane with a radius of .9 μm toward the cell. The extension of Geant4-DNA [30] was used to define a suitable model of physical interactions in micrometer scale. For alpha particles, the physics package of "G4EmDNAPhy-sics_option2" includes G4DNAIonElasticModel, G4DNA-MillerGreenExcitationModel, G4DNARuddIonisationModel, and G4DNADingfelderChargeDecrease Model for nuclear scattering (100 eV1 MeV), electronic excitation (.1400 MeV), ionization (0400 MeV), and electron capture (.1400 MeV), respectively. For electrons, the implemented physics models are G4DNABornExcitationModel, G4DNAChampionElasticModel, G4DNABornIonisationModel, G4DNAMeltonAttachmentModel, and G4DNASanche ExcitationModel for electronic excitation (9 eV1 MeV), elastic scattering (7.4 eV1 MeV), ionization (11 eV1 MeV), molecular attachment (413 eV), and vibrational excitation (2100 eV), respectively. The default energy cutoff for electrons is 7.4 eV, below which the transport of electrons would stop and their remaining energy would be deposited locally [31] .

Although the effects of smoking on suppressing the SARS-CoV-2 receptor are not definitively established, it appears possible that positive effects might occur for light smoking activity (smoking 1-39 cigarettes per week). This effect is attributed to the presence of radioactive polonium-210 and lead-210 in tobacco and cigarette smoke. The associated alpha emission from these naturally occurring radionuclides leads to exposure of the alveolar epithelial cells that line the alveoli. This energy deposition may trigger both anti-inflammatory and anti-thrombosis effects and eventually lower the risk of hospitalization due to COVID-19.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Pooya Saraie  https://orcid.org/0000-0002-5465-8313 Seyed Mohammad Javad Mortazavi  https://orcid.org/0000-0003-0139-2774

Signaling pathway perturbation analysis for assessment of biological impact of cigarette smoke on lung cells

COVID-19 and smoking: A systematic review of the evidence

Smoking and COVID-19: Adding fuel to the flame

Active smoking is associated with severity of coronavirus disease 2019 (COVID-19 ): An update of a meta-analysis

Low rate of daily active tobacco smoking in patients with symptomatic COVID-19

Risk factors for SARS-CoV-2 among patients in the Oxford royal college of general practitioners research and surveillance centre primary care network: A cross-sectional study

Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients

Smoking and COVID-19 Outcomes: An Observational and Mendelian Randomisation Study Using the UK Biobank Cohort

Impact of tobacco smoking on the risk of COVID-19: A large scale retrospective cohort study

What is Happening with Smokers and COVID-19?

Current smoking is not associated with COVID-19

Nicotine and the renin-angiotensin system

The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7)

Smoking, vaping and hospitalization for COVID-19

Factors associated with COVID-19-related death using OpenSAFELY

Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensinconverting enzyme 2, via aryl-hydrocarbon receptor signal

Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19

Expression of the SARS-CoV-2 ACE2 receptor in the human airway epithelium

COVID-19 and nicotine as a mediator of ACE-2

Smoking and COVID-19: Similar bronchia-lACE2 and TMPRSS2expression and higherTMPRSS4expression in current versus never smokers

Why do some reports claim that the number of COVID-19 hospitalized smokers is smaller than expected

The Chemical Components of Tobacco and Tobacco Smoke

Comprehensive characterization of mainstream marijuana and tobacco smoke

A complex matrix characterization approach, applied to cigarette smoke, that integrates multiple analytical methods and compound identification strategies for non-targeted liquid chromatography with high-resolution mass spectrometry

In vitro mutagenicity of gas-vapour phase extracts from flavoured and unflavoured heated tobacco products

210Po as a source of natural radioactivity in cigarettes distributed in the philippines. Perspectives in Science

Comprehensive survey of radionuclides in contemporary smokeless tobacco products

Natural radionuclides in cigarette tobacco from serbian market and effective dose estimate from smoke inhalation

Natural radioactivity contents in tobacco and radiation dose induced from smoking

Alpha radioactivity in tobacco leaves: Effect of fertilizers

Human exposure to radioactivity from tobacco smoke: Systematic review

Radioactivity of tobacco leaves and radiation dose induced from smoking

Low doses of radiation increase the immunosuppressive profile of lung macrophages during viral infection and pneumonia

COVID-19: The disease, the immunological challenges, the treatment with pharmaceuticals and low-dose ionizing radiation

Low-dose whole-lung irradiation for COVID-19 pneumonia: Final results of a pilot study

Low-dose whole-lung irradiation for COVID-19 pneumonia: Short course results

Waking a sleeping giant: The tobacco industry's response to the polonium-210 issue

Polonium-210: A volatile radioelement in cigarettes

Radioactivity in cigarette smoking

Low-dose radiation as a treatment for COVID-19 pneumonia: A threat or real opportunity?

Low-dose radiation therapy for COVID-19: A systematic review